Liquidia Corp. (LQDA)
61.97
+0.20
(+0.32%)
USD |
NASDAQ |
May 21, 16:00
62.15
+0.18
(+0.29%)
After-Hours: 19:59
Liquidia Research and Development Expense (TTM) : 44.01M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 51.70M |
| Indivior Pharmaceuticals, Inc. | 67.00M |
| Lexicon Pharmaceuticals, Inc. | 58.02M |
| Terns Pharmaceuticals, Inc. (DELISTED) | 77.89M |
| Emmaus Life Sciences, Inc. | 0.177M |